BEYOND AIR INC (XAIR) Fundamental Analysis & Valuation

NASDAQ:XAIR • US08862L2025

Current stock price

0.4986 USD
+0.01 (+2.36%)
Last:

This XAIR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. XAIR Profitability Analysis

1.1 Basic Checks

  • In the past year XAIR has reported negative net income.
  • XAIR had a negative operating cash flow in the past year.
  • In the past 5 years XAIR always reported negative net income.
  • XAIR had a negative operating cash flow in each of the past 5 years.
XAIR Yearly Net Income VS EBIT VS OCF VS FCFXAIR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20M -40M -60M

1.2 Ratios

  • XAIR has a Return On Assets of -84.30%. This is in the lower half of the industry: XAIR underperforms 78.07% of its industry peers.
  • With a Return On Equity value of -382.21%, XAIR is not doing good in the industry: 84.49% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -84.3%
ROE -382.21%
ROIC N/A
ROA(3y)-114.02%
ROA(5y)-88.4%
ROE(3y)-243.66%
ROE(5y)-173.09%
ROIC(3y)N/A
ROIC(5y)N/A
XAIR Yearly ROA, ROE, ROICXAIR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200 -400 -600 -800 -1K

1.3 Margins

  • XAIR's Gross Margin of 1.82% is on the low side compared to the rest of the industry. XAIR is outperformed by 81.82% of its industry peers.
  • The Profit Margin and Operating Margin are not available for XAIR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 1.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
XAIR Yearly Profit, Operating, Gross MarginsXAIR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K -4K -5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. XAIR Health Analysis

2.1 Basic Checks

  • XAIR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • XAIR has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for XAIR has been increased compared to 5 years ago.
  • Compared to 1 year ago, XAIR has a worse debt to assets ratio.
XAIR Yearly Shares OutstandingXAIR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M
XAIR Yearly Total Debt VS Total AssetsXAIR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.2 Solvency

  • XAIR has an Altman-Z score of -13.41. This is a bad value and indicates that XAIR is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -13.41, XAIR is not doing good in the industry: 85.56% of the companies in the same industry are doing better.
  • XAIR has a Debt/Equity ratio of 2.71. This is a high value indicating a heavy dependency on external financing.
  • XAIR has a worse Debt to Equity ratio (2.71) than 86.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.71
Debt/FCF N/A
Altman-Z -13.41
ROIC/WACCN/A
WACC8.96%
XAIR Yearly LT Debt VS Equity VS FCFXAIR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M 60M -60M

2.3 Liquidity

  • A Current Ratio of 5.12 indicates that XAIR has no problem at all paying its short term obligations.
  • XAIR has a Current ratio of 5.12. This is in the better half of the industry: XAIR outperforms 76.47% of its industry peers.
  • XAIR has a Quick Ratio of 4.77. This indicates that XAIR is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 4.77, XAIR is in the better half of the industry, outperforming 78.07% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.12
Quick Ratio 4.77
XAIR Yearly Current Assets VS Current LiabilitesXAIR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. XAIR Growth Analysis

3.1 Past

  • XAIR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 74.48%, which is quite impressive.
  • XAIR shows a strong growth in Revenue. In the last year, the Revenue has grown by 129.04%.
  • XAIR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.66% yearly.
EPS 1Y (TTM)74.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.33%
Revenue 1Y (TTM)129.04%
Revenue growth 3YN/A
Revenue growth 5Y21.66%
Sales Q2Q%104.66%

3.2 Future

  • Based on estimates for the next years, XAIR will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.55% on average per year.
  • Based on estimates for the next years, XAIR will show a very strong growth in Revenue. The Revenue will grow by 80.94% on average per year.
EPS Next Y74.82%
EPS Next 2Y37.37%
EPS Next 3Y23.83%
EPS Next 5Y14.55%
Revenue Next Year105.93%
Revenue Next 2Y80.47%
Revenue Next 3Y95.34%
Revenue Next 5Y80.94%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
XAIR Yearly Revenue VS EstimatesXAIR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M 400M 500M
XAIR Yearly EPS VS EstimatesXAIR Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 10 -10 -20 -30

More info and screens

Find the best growth stocksShow best growing peers

1

4. XAIR Valuation Analysis

4.1 Price/Earnings Ratio

  • XAIR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year XAIR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XAIR Price Earnings VS Forward Price EarningsXAIR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XAIR Per share dataXAIR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4

4.3 Compensation for Growth

  • XAIR's earnings are expected to grow with 23.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.37%
EPS Next 3Y23.83%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. XAIR Dividend Analysis

5.1 Amount

  • XAIR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

XAIR Fundamentals: All Metrics, Ratios and Statistics

BEYOND AIR INC

NASDAQ:XAIR (4/28/2026, 10:42:41 AM)

0.4986

+0.01 (+2.36%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-13
Earnings (Next)06-15
Inst Owners13.96%
Inst Owner Change10.04%
Ins Owners2.73%
Ins Owner Change0%
Market Cap5.25M
Revenue(TTM)6.92M
Net Income(TTM)-31.00M
Analysts80
Price Target7.91 (1486.44%)
Short Float %0.66%
Short Ratio0.21
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-21.44%
Min EPS beat(2)-43.33%
Max EPS beat(2)0.46%
EPS beat(4)2
Avg EPS beat(4)-5.58%
Min EPS beat(4)-43.33%
Max EPS beat(4)27.68%
EPS beat(8)6
Avg EPS beat(8)3.95%
EPS beat(12)8
Avg EPS beat(12)-0.21%
EPS beat(16)9
Avg EPS beat(16)-9.81%
Revenue beat(2)1
Avg Revenue beat(2)-14.03%
Min Revenue beat(2)-28.34%
Max Revenue beat(2)0.27%
Revenue beat(4)1
Avg Revenue beat(4)-12.01%
Min Revenue beat(4)-28.34%
Max Revenue beat(4)0.27%
Revenue beat(8)2
Avg Revenue beat(8)-14.34%
Revenue beat(12)2
Avg Revenue beat(12)-30.25%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-13.89%
EPS NQ rev (1m)0%
EPS NQ rev (3m)7.33%
EPS NY rev (1m)1.18%
EPS NY rev (3m)-15.96%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-11.14%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.57%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.76
P/FCF N/A
P/OCF N/A
P/B 0.65
P/tB 0.75
EV/EBITDA N/A
EPS(TTM)-5.41
EYN/A
EPS(NY)-1.78
Fwd EYN/A
FCF(TTM)-2.1
FCFYN/A
OCF(TTM)-1.91
OCFYN/A
SpS0.66
BVpS0.77
TBVpS0.67
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -84.3%
ROE -382.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 1.82%
FCFM N/A
ROA(3y)-114.02%
ROA(5y)-88.4%
ROE(3y)-243.66%
ROE(5y)-173.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 2.71
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 60.56%
Cap/Sales 28.54%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.12
Quick Ratio 4.77
Altman-Z -13.41
F-Score5
WACC8.96%
ROIC/WACCN/A
Cap/Depr(3y)311.89%
Cap/Depr(5y)350.75%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)74.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.33%
EPS Next Y74.82%
EPS Next 2Y37.37%
EPS Next 3Y23.83%
EPS Next 5Y14.55%
Revenue 1Y (TTM)129.04%
Revenue growth 3YN/A
Revenue growth 5Y21.66%
Sales Q2Q%104.66%
Revenue Next Year105.93%
Revenue Next 2Y80.47%
Revenue Next 3Y95.34%
Revenue Next 5Y80.94%
EBIT growth 1Y41.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year98.55%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y62.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y62.49%
OCF growth 3YN/A
OCF growth 5YN/A

BEYOND AIR INC / XAIR Fundamental Analysis FAQ

What is the fundamental rating for XAIR stock?

ChartMill assigns a fundamental rating of 3 / 10 to XAIR.


Can you provide the valuation status for BEYOND AIR INC?

ChartMill assigns a valuation rating of 1 / 10 to BEYOND AIR INC (XAIR). This can be considered as Overvalued.


Can you provide the profitability details for BEYOND AIR INC?

BEYOND AIR INC (XAIR) has a profitability rating of 0 / 10.


What is the earnings growth outlook for BEYOND AIR INC?

The Earnings per Share (EPS) of BEYOND AIR INC (XAIR) is expected to grow by 74.82% in the next year.